Newsroom

Selexis has been setting the pace of innovation in protein expression and establishing new benchmarks in bioproduction for  two decades.

1 min read

Selexis SA to Present at Biotech Showcase 2012

Jan 5, 2012 12:56:39 PM

Dr. Igor Fisch to Present in the Private Company Track

Geneva, Switzerland (PRWEB) January 5, 2012 – Selexis SA announced today the Company’s president and CEO, Igor Fisch, PhD, will present at the Biotech Showcase 2012 Conference held in conjunction with the annual J.P. Morgan Healthcare Conference in San Francisco, CA.

Dr. Fisch will present, “Translating Drug Discovery into Clinical Success: A Growth Investment” to prospective investors and corporate partners on Monday, January 9 at 11:00 AM in the Stockton Room at the Park 55 Wyndham. The presentation will cover existing commercial offerings, the expansion of the SUREtechnology Platform™ and new market opportunities in drug discovery, next generation biologics and difficult to express proteins.

“Biotech Showcase is an ideal opportunity for us to highlight our innovations and our applications of the SUREtechnology Platform™ supporting the biopharmaceutical industry’s drug discovery efforts,” said Dr. Fisch. “Using Selexis’ platform from discovery through manufacturing helps improve chances of clinical success while reducing development timelines and costs.”

Topics: 2012

Featured